Virginia Drug Discovery Consortium

The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:

To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.

To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.

To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.


New Research Specialist Laboratory Technician Position Available

KeViRx is a Charlottesville, Virginia, based early stage pharmaceutical company, and recently
received funding from the Commonwealth Research Commercialization Fund. We seek to fill an
R&D laboratory position to assist with this grant focused on developing new cancer
therapeutics. The ideal candidate would have a BS degree in Biology or Chemistry and
laboratory experience with biochemical assays, protein determinations, molecular biology
techniques, mammalian cell culturing methodologies and data analyses. More information
concerning KeViRx can be found on our website ( Individuals who are
interested in this position should contact Elizabeth R. Sharlow (



VirginiaDrugDiscoveryRx: Targets to Translation

Double Tree Hotel, Midlothian, VA – May 18 – 19, 2020

The VaDDC Executive Committee regrets to announce this event has been canceled until next year due to the COVID-19 pandemic.


Virginia Bio Names John Newby CEO

Virginia Bio Names John Newby CEO

Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...

read more


Virginia Tech
Virginia Biosciences Health Research Corporation

Want to work with us?

If you are interested in supporting this initiative, please contact us.